NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
114 hedge funds and large institutions have $541M invested in NxStage Medical Inc. in 2013 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 20 closing their positions.
964% more call options, than puts
Call options by funds: $266K | Put options by funds: $25K
29% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 35
1% less funds holding
Funds holding: 115 → 114 (-1)
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
23% less capital invested
Capital invested by funds: $705M → $541M (-$164M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$10.8M |
| 2 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$9.73M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$9.31M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$7.84M |
| 5 |
DM
Deerfield Management
New York
|
+$6.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$21.6M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$14.7M |
| 3 |
FAM
Fred Alger Management
New York
|
-$13.9M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$6.8M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$5.32M |
NXTM Hedge Fund Activity: Q4 2013 in Review
114 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2013, worth a combined $541M — down 23% from $705M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of NXTM and 19 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 45 added.
The largest buyer was Oracle Investment Management, adding an estimated $10.8M. The largest seller was Wells Fargo, cutting an estimated $21.6M.
- 114 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2013, down from 115 in Q3 2013.
- Funds reported $541M of NxStage Medical Inc. stock for Q4 2013, down 23% quarter-over-quarter.
- 19 funds opened new NxStage Medical Inc. positions in Q4 2013 and 20 closed out, a net change of -1 holder.
- The largest NxStage Medical Inc. buyer in Q4 2013 was Oracle Investment Management, an estimated $10.8M added.
- The largest NxStage Medical Inc. seller in Q4 2013 was Wells Fargo, an estimated $21.6M sold.
Based on aggregated 13F filings for Q4 2013.